Other News To Note
InterMune Inc., of Brisbane, Calif., said the Swedish Dental and Pharmaceutical Benefits Agency included Esbriet (pirfenidone) on the country's list of reimbursed drugs, making Esbriet the first therapeutic treatment for idiopathic pulmonary fibrosis to be reimbursed in Sweden.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST